These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 27175090)
21. Relationship between ABCB1 polymorphisms and serum methadone concentration in patients undergoing methadone maintenance therapy (MMT). Zahari Z; Lee CS; Ibrahim MA; Musa N; Mohd Yasin MA; Lee YY; Tan SC; Mohamad N; Ismail R Am J Drug Alcohol Abuse; 2016 Sep; 42(5):587-596. PubMed ID: 27284701 [TBL] [Abstract][Full Text] [Related]
22. Pharmacogenomic associations in ABCB1 and CYP3A5 with acute kidney injury and chronic kidney disease after myeloablative hematopoietic cell transplantation. Woodahl EL; Hingorani SR; Wang J; Guthrie KA; McDonald GB; Batchelder A; Li M; Schoch HG; McCune JS Pharmacogenomics J; 2008 Aug; 8(4):248-55. PubMed ID: 17700595 [TBL] [Abstract][Full Text] [Related]
23. Associations of ABCB1, ABCC2, and ABCG2 polymorphisms with irinotecan-pharmacokinetics and clinical outcome in patients with advanced non-small cell lung cancer. Han JY; Lim HS; Yoo YK; Shin ES; Park YH; Lee SY; Lee JE; Lee DH; Kim HT; Lee JS Cancer; 2007 Jul; 110(1):138-47. PubMed ID: 17534875 [TBL] [Abstract][Full Text] [Related]
24. Influence of ABCB1 polymorphisms on the pharmacokinetics and toxicity of lenalidomide in patients with multiple myeloma. Kobayashi T; Miura M; Abumiya M; Akamine Y; Ito F; Takahashi N Med Oncol; 2019 May; 36(6):55. PubMed ID: 31089832 [TBL] [Abstract][Full Text] [Related]
25. Association of ABCB1 polymorphisms with the antiemetic efficacy of granisetron plus dexamethasone in breast cancer patients. Tsuji D; Kim YI; Nakamichi H; Daimon T; Suwa K; Iwabe Y; Hayashi H; Inoue K; Yoshida M; Itoh K Drug Metab Pharmacokinet; 2013; 28(4):299-304. PubMed ID: 23358260 [TBL] [Abstract][Full Text] [Related]
26. Association of a polymorphism in the ABCB1 gene with Parkinson's disease. Westerlund M; Belin AC; Anvret A; Håkansson A; Nissbrandt H; Lind C; Sydow O; Olson L; Galter D Parkinsonism Relat Disord; 2009 Jul; 15(6):422-4. PubMed ID: 19196542 [TBL] [Abstract][Full Text] [Related]
27. Effects of genetic polymorphisms in the ABCB1 gene on clinical outcomes in patients with gastric cancer treated by second-line chemotherapy. Shitara K; Matsuo K; Ito S; Sawaki A; Kawai H; Yokota T; Takahari D; Shibata T; Ura T; Ito H; Hosono S; Kawase T; Watanabe M; Tajima K; Yatabe Y; Tanaka H; Muro K Asian Pac J Cancer Prev; 2010; 11(2):447-52. PubMed ID: 20843132 [TBL] [Abstract][Full Text] [Related]
28. Do drug transporter (ABCB1) SNPs influence cyclosporine and tacrolimus dose requirements and renal allograft outcome in the posttransplantation period? Singh R; Srivastava A; Kapoor R; Mittal RD J Clin Pharmacol; 2011 Apr; 51(4):603-15. PubMed ID: 20571034 [TBL] [Abstract][Full Text] [Related]
29. Correlation between clinical response to sorafenib in hepatocellular carcinoma treatment and polymorphisms of P-glycoprotein (ABCB1) and of breast cancer resistance protein (ABCG2): monocentric study. Tandia M; Mhiri A; Paule B; Saffroy R; Cailliez V; Noé G; Farinotti R; Bonhomme-Faivre L Cancer Chemother Pharmacol; 2017 Apr; 79(4):759-766. PubMed ID: 28289864 [TBL] [Abstract][Full Text] [Related]
30. Association of ABCB1 genetic variants 3435C>T and 2677G>T to ABCB1 mRNA and protein expression in brain tissue from refractory epilepsy patients. Mosyagin I; Runge U; Schroeder HW; Dazert E; Vogelgesang S; Siegmund W; Warzok RW; Cascorbi I Epilepsia; 2008 Sep; 49(9):1555-61. PubMed ID: 18494787 [TBL] [Abstract][Full Text] [Related]
31. Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part II. Staatz CE; Goodman LK; Tett SE Clin Pharmacokinet; 2010 Apr; 49(4):207-21. PubMed ID: 20214406 [TBL] [Abstract][Full Text] [Related]
32. Influence of adenosine triphosphate and ABCB1 (MDR1) genotype on the P-glycoprotein-dependent transfer of saquinavir in the dually perfused human placenta. Rahi M; Heikkinen T; Hakkola J; Hakala K; Wallerman O; Wadelius M; Wadelius C; Laine K Hum Exp Toxicol; 2008 Jan; 27(1):65-71. PubMed ID: 18480151 [TBL] [Abstract][Full Text] [Related]
33. Influence of ABCB1 and CYP3A5 genetic polymorphisms on the pharmacokinetics of quetiapine in healthy volunteers. Kim KA; Joo HJ; Lee HM; Park JY Pharmacogenet Genomics; 2014 Jan; 24(1):35-42. PubMed ID: 24240480 [TBL] [Abstract][Full Text] [Related]
34. Impact of ABCB1 single nucleotide polymorphisms 1236C>T and 2677G>T on overall survival in FLT3 wild-type de novo AML patients with normal karyotype. Jakobsen Falk I; Fyrberg A; Paul E; Nahi H; Hermanson M; Rosenquist R; Höglund M; Palmqvist L; Stockelberg D; Wei Y; Gréen H; Lotfi K Br J Haematol; 2014 Dec; 167(5):671-80. PubMed ID: 25155901 [TBL] [Abstract][Full Text] [Related]
35. Relationship between ABCB1 gene polymorphisms and severe neutropenia in patients with breast cancer treated with doxorubicin/cyclophosphamide chemotherapy. Ikeda M; Tsuji D; Yamamoto K; Kim YI; Daimon T; Iwabe Y; Hatori M; Makuta R; Hayashi H; Inoue K; Nakamichi H; Shiokawa M; Itoh K Drug Metab Pharmacokinet; 2015 Apr; 30(2):149-53. PubMed ID: 25989890 [TBL] [Abstract][Full Text] [Related]
36. Polymorphisms of genes encoding drug transporters or cytochrome P450 enzymes and association with clinical response in cancer patients: a systematic review. Kulma I; Boonprasert K; Na-Bangchang K Cancer Chemother Pharmacol; 2019 Nov; 84(5):959-975. PubMed ID: 31482229 [TBL] [Abstract][Full Text] [Related]
37. Influence of ABCB1 polymorphisms upon the effectiveness of standard treatment for acute myeloid leukemia: a systematic review and meta-analysis of observational studies. Megías-Vericat JE; Rojas L; Herrero MJ; Bosó V; Montesinos P; Moscardó F; Poveda JL; Sanz MÁ; Aliño SF Pharmacogenomics J; 2015 Apr; 15(2):109-18. PubMed ID: 25558979 [TBL] [Abstract][Full Text] [Related]
38. Genetic polymorphisms in the ABCB1 gene and the effects of fentanyl in Koreans. Park HJ; Shinn HK; Ryu SH; Lee HS; Park CS; Kang JH Clin Pharmacol Ther; 2007 Apr; 81(4):539-46. PubMed ID: 17192767 [TBL] [Abstract][Full Text] [Related]
39. A drug transporter for all ages? ABCB1 and the developmental pharmacogenetics of cyclosporine. Hesselink DA; van Schaik RH; Nauta J; van Gelder T Pharmacogenomics; 2008 Jun; 9(6):783-9. PubMed ID: 18518855 [TBL] [Abstract][Full Text] [Related]
40. P-glycoprotein: tissue distribution, substrates, and functional consequences of genetic variations. Cascorbi I Handb Exp Pharmacol; 2011; (201):261-83. PubMed ID: 21103972 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]